5/8/2023NMPA Issues the List of Reference Formulations for GQCE Studies (67th ...

5/5/2023NMPA Begins a New Round of Comment Seeking on the Provisions on Drug S...

5/4/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (69...

5/4/2023ChP Commission Publicizes Chinese Generic Names of Biologics in the WH...

5/4/2023NIFDC Solicits Public Comments on Revision of the Guidelines for Drug ...

5/3/2023CDE Solicits Comments on Implementation Suggestions for ICH Guidelines...

5/3/2023CDE Issues the Technical Guidelines for Clinical R&D of Anti-Tumor Pho...

4/28/2023NMPA Announces OTC Switch of Four Rx Drug Products

4/27/2023CDE Issues the Technical Guidelines for Clinical Trials of Chronic Hep...

4/27/2023CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...

4/26/2023CDE Issues the Technical Guidelines for Clinical Trials of Active Immu...

4/26/2023CDE Solicits Comments on Draft Implementation Suggestions of ICH Guide...

4/26/2023CFDI Solicits Public Comments on the Inspection Points and Judgment Pr...

4/26/2023CFDI Issues the Dossier Requirements for GLP Certification of Drug Non...

4/25/2023NMPA Issues the Opinions for Improving Review and Approval of Radiopha...

4/25/2023NMPA Announces Package Insert Revision of Additional Two Drug Products

4/24/2023NMPA Announces Package Insert Revision of Multiple Drug Products

4/24/2023NMPA Issues Announcement for Applicability of ICH Guidelines E19

4/21/2023NMPA Issues the 2022 Drug Regulatory Statistics Annual Report

Page:9/9 Total number of articles:259: [First][<<] [5] [6] [7] [8] [9] [>>] [End]